Microbix Biosystems (MBXBF) announces the voting results from the Annual Meeting of Shareholders of the Company which was held on March 25. At the Meeting, 27.44% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolutions that were voted upon are set out in the Management Information Circular dated February 6. All of the board of directors nominees listed in the Circular were re-elected as directors of Microbix. Shareholders also approved a resolution re-appointing the Company’s auditors, Ernst & Young LLP, with 96.66% of the votes cast in favour.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBXBF:
- Microbix Unveils Normalized HPV Reference Materials to Strengthen Assay Validation
- Microbix Biosystems presents results of QUANTDx reference materials
- Microbix Advances Modernized Manufacturing for Kinlytic Clot-Buster Drug
- Microbix Biosystems announces advancement of clot-buster drug project
- Microbix Issues New Stock Options to Retain Senior Talent and Manage Dilution
